Canon Inc logo

7751 - Canon Inc News Story

¥1901 14.0  0.7%

Last Trade - 14/08/20

Sector
Technology
Size
Large Cap
Market Cap £14.23bn
Enterprise Value £16.11bn
Revenue £23.47bn
Position in Universe 66th / 3863

BRIEF-Canon Medical To Commence Development Of A Rapid Genetic Testing System For Coronavirus

Thu 19th March, 2020 10:14pm
March 19 (Reuters) - Canon Inc  7751.T :
    * CANON MEDICAL TO COMMENCE DEVELOPMENT OF A RAPID GENETIC
TESTING
SYSTEM FOR NOVEL CORONAVIRUS (COVID-19)
    * CANON U.S.A. - PROJECT PART OF A RESEARCH PROGRAM FOCUSING
ON
DEVELOPMENT OF DIAGNOSTIC METHODS FOR COVID-19 LED BY JAPAN
AGENCY FOR MEDICAL RESEARCH

Source text for Eikon:  ID:nPnbRrkzQa 
Further company coverage:  7751.T 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.